Literature DB >> 18448015

[Knowledge of and attitudes and adherence to the Spanish Guidelines for Asthma Management (GEMA) among Spanish health care professionals: the GEMA test Project].

Vicente Plaza1, Ignasi Bolívar, Jordi Giner, María Antonia Llauger, Antolín López-Viña, José Antonio Quintano, Joaquín Sanchis, Montserrat Torrejón, José Ramón Villa.   

Abstract

OBJECTIVE: Health care professionals' adherence to asthma guidelines is believed to be low. The aim of the present study was to determine the knowledge, attitudes, and adherence of Spanish health care professionals with respect to the Spanish Guidelines for Asthma Management (GEMA).
MATERIAL AND METHODS: A multiple choice test with 15 questions was constructed. Items assessed knowledge of and opinions and adherence to asthma guidelines in general and the GEMA in particular. Test completion was voluntary, individual, and anonymous.
RESULTS: A total of 1,066 physicians and nurses took the test. The sample consisted of 241 (22.6%) respiratory medicine specialists and 244 (22.9%) nurses from the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR), 221 (20.7%) pediatric pulmonologists from the Spanish Society of Pediatric Pulmonology (SENP), 220 (20.6%) general practitioners from the Spanish Society of Family and Community Medicine (semFYC), 181 (17%) general practitioners from the Spanish Society of Rural and General Medicine (SEMERGEN), and 38 (3.6%) others. Asthma guidelines were considered useful or very useful by 805 (76%), and 771 (72%) stated they were familiar with the GEMA. However, 388 (36%) admitted that they followed guidelines seldom or never. The level of adherence to the GEMA was poor for 243 (30.3%) respondents. The multivariate analysis revealed that low adherence was associated with the following characteristics: coming from the geographic center or south of Spain; being a primary care physician, unfamiliar with guidelines, or unconvinced of their utility; and not being a user of spirometry.
CONCLUSIONS: Even though the majority of Spanish health care professionals surveyed seem to know of the GEMA, their adherence to those guidelines is very low. Educational programs that seek to improve knowledge of asthma guidelines should consider the profile of professionals with low adherence to the GEMA so as to include educational strategies that target them specifically.

Entities:  

Mesh:

Year:  2008        PMID: 18448015

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  4 in total

1.  Documentation of the management of asthma exacerbation in adults by primary health care physicians in a teaching hospital in oman.

Authors:  Sawsan A Baddar; Aida I Al-Ismaili; Muna A Al-Taie; Abdulaziz M Al-Mahrezi; Omar A Al-Rawas
Journal:  Sultan Qaboos Univ Med J       Date:  2010-11-14

2.  Prevalence of asthma symptoms in schoolchildren, and climate in west European countries: an ecologic study.

Authors:  Alberto Arnedo-Pena; Luis García-Marcos; Alberto Bercedo-Sanz; Inés Aguinaga-Ontoso; Carlos González-Díaz; Agueda García-Merino; Rosa Busquets-Monge; Maria Morales Suárez-Varela; Juan Batlles-Garrido; Alfredo A Blanco-Quirós; Angel López-Silvarrey; Gloria García-Hernández; Jorge Fuertes
Journal:  Int J Biometeorol       Date:  2012-11-14       Impact factor: 3.787

Review 3.  Asthma referrals: a key component of asthma management that needs to be addressed.

Authors:  David Price; Leif Bjermer; David A Bergin; Rafael Martinez
Journal:  J Asthma Allergy       Date:  2017-07-25

4.  An online survey detected knowledge gaps and cost-saving opportunities in asthma maintenance treatment among allergists, pulmonologists, ENTs and primary care.

Authors:  Larenas-Linnemann Désirée; Fernández-Vega Margarita; Rodríguez-González Mónica; Cano-Salas María Del Carmen; Luna-Pech Jorge Agustín; Ortega-Martell José Antonio; Del Rio-Navarro Blanca; López-Estrada Erika Del Carmen; Romero-Lombard Jade; Vázquez-García Juan Carlos; Salas-Pérez Jorge
Journal:  World Allergy Organ J       Date:  2019-11-19       Impact factor: 4.084

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.